Mastitis Case Study

1097 Words3 Pages

The Food and Drug Administration, World Health Organization, American Medical Association, American Dietetic Association, and the National Institute of Health have stated that not only dairy but also meat from rBST cows is safe for human consumption (Brennand, 1999). So even when the BST is destroyed in pasteurization and the IGF-I is not. Consuming the last one orally is just not a concern (Brennand & Bagley, 1999).
Mastitis is the inflammation of the mammary gland on bovines. In most cases it is produced by microorganism, invading and multiplying inside the udder. This bacteria population produces toxins that degrade and wound the udder. Mastitis could be Clinical and sub clinical. Over 100 kinds of bacteria are proven to cause Mastitis in both grades; also high temperatures are proven to cause a mastitis blemish. Because of this, mastitis rooted in infected population of cows is hard to determine (Schroeder, 2012).
The infection not only changes the nutritional value of the milk but also low milk production and, depending of the grade of the infection, the milk from that cow will no longer be marketable, representing time and money lost to the farmer …show more content…

The farmer must pay for the product ($5.25 per dose if the product is used on at least 60 percent of the herd 's cows). The cow must eat more feed to support her increased milk production. The revenue comes from the sale of the extra milk, typically 8 to 12 pounds per cow per day at a price of 11 to 15 cents per pound. This cycle is repeated every 14 days, as the cow is re-injected. For some farms, there are additional costs for extra labor to sort and inject the cows. In general, there are few, if any, capital costs involved in the use. On some farms, alterations to the cow handling or feeding systems are needed to adopt rBST use, but generally these costs are small compared to the profit and break-even. Payback is quickly achieved (Fetrow,

Open Document